Vox Markets Logo

Hybridan Small Cap Feast: 23/11/2023

10:45, 23rd November 2023
TwitterFacebookLinkedIn

Banquet Buffet*** 

 

Cambridge Nutritional Sciences 2.55p £6.1m (CNSL.L) 

The medical diagnostics Company focused on promoting personalised approach to health and nutrition announces its unaudited interim results for the six months ended 30 September 2023. Revenue increased 44% to £4.9m (H1 2022: £3.4m), as a result gross margin increased to 62.7% (H1 2022: 54.0%), and adjusted EBITDA came in at £0.0m (H1 2022: restated loss £0.4m). The Company announced a loss before tax of £0.7m (H1 2022: restated loss £0.8m) and holds a cash balance of £4.4m. The Company announced strong performance in operations with FoodPrint in which its yields improved and the Company’s first USA laboratory commercialising FoodPrint was operational. The Company is on track to meet market expectations for the full year. 

 

First Property Group 16.5p  £18.3m (FPO.L) 

The fund manager and investor with operations in the UK and Central Europe announces its interim results for the six months ended 30 September 2023. Revenue was £3.97m, the statutory loss before tax £0.65m (30 September 2022 profit before tax: £2.39m), and total AUM reduced by 21% to £358m (31 March 2023: £454m). The Company holds cash of £6.71m and net debt of £22.22m. With inflation reducing and interest rates close to their peak, the Group are looking forward to the future. 

 

Hornby 16p £27.2m (HRN.L) 

The international hobby products Group announces its unaudited interim results for the six months ended 30 September 2023. Group revenue was £23.8m (2022: £22.4m) an increase of 6% on the prior year, and underlying Operating Group loss before tax was £4.2m (2022: loss of £1.5m). The Company has net debt of £14.6m (September 2022: Net debt £4.9m), and holds cash at 30 September 2023 of £1m. The Company launched its first retail experience under the name The WonderWork. Hornby expects profitability to be depressed in 2023/2024. 

 

Intelligent Ultrasound 8.88p £29.0m (IUG.L) 

The 'classroom to clinic' ultrasound Company specialising in artificial intelligence (AI) software and simulation, announces a new AI development programme for gestational age estimation in prenatal care. ScanNav FetalCheck scanning technology aims to enable a non-skilled or skilled user to establish the gestational age accurately with minimal training. It aims to transform antenatal care Globally. Intelligent Ultrasound also announces that a university in Africa has purchased four ScanNav FetalCheck systems as part of a trial to evaluate biomarkers and other factors which affect the probability of stillbirth. ScanNav FetalCheck is currently not licenced for clinical use. 

 

Longboat Energy  18.25p £10.3m (LBE.L) 

An full-cycle E&P Company active in Norway and Malaysia provides an operational update. On 3 July 2023, Longboat announced that it had signed a sale and purchase agreement with INPEX Idemitsu to acquire a 9.60% interest in PL 089, equating to a 4.80% unitised interest in the Statfjord Øst Unit and a 4.32% unitised interest in the Sygna Unit, for cash consideration of US$12.75m. Initial production for 2023 is estimated to be around 250 boepd net to Longboat JAPEX, which is slightly lower than anticipated. Longboat remains strategically focused on delivering value-accretive M&A opportunities across both of its key regions of Norway and South East Asia. 

 

Michelmersh Brick Holdings 82p £76.8m (MBH.L) 

The brick manufacturer announces a trading update in relation to its financial results for the year ending 31 December 2023. The trading performance of the Group has been resilient in the final quarter of the financial year as they have continued to operate at full manufacturing capacity to deliver the forward order book. The Company continue to focus on controlling input costs and the efficiency of its facilities within this environment. The Board expects revenue, profit and cash for the Group to be in-line with market expectations for the 12 months ending 31 December 2023. 

 

Mirriad Advertising 2.7p £10.8m (MIRI.L) 

The in-content advertising Company announces that further to the Company's announcement on 13 October 2023, Nic Hellyer has been appointed to the Board of the Company as Chief Financial Officer with immediate effect. Nic joins the Company with over 30 years of financial and listed company experience, having held various senior banking director and CFO roles. David Dorans will remain on the Board of Mirriad as an Executive Director until 31 December 2023. 

 

Sareum Holdings* 60p  £42.2m (SAR.L) 

A biotechnology Company developing next generation kinase inhibitors for autoimmune disease and cancer announces that it has drawn down on the £0.3m Second Deposit in respect of the Equity Prepayment Facility announced on 3 August 2023. In accordance with the terms of the Equity Prepayment Facility, the Company will issue 227,892 four year warrants over ordinary shares of 1.25p each exercisable at a price of £0.829337 to Riverfort. 

 

United Oil & Gas 0.78p £5.1m (UOG.L) 

The full-cycle oil and gas Company with a portfolio of production, development, exploration and appraisal assets, issues a Corporate update. The Company announces that Simon Brett has been appointed Interim Chief Financial Officer (non board appointment) and Company Secretary, effective immediately. Simon brings a wealth of sectoral and public markets experience having worked fourteen years in Barryroe Offshore Energy plc. The Company continues to engage with the Jamaican authorities to secure an extension to the current license period which expires at the end of January 2024, that comprises additional technical work that would further de-risk the license prior to the drilling of the exploration well.  

 

Windward 72p  £61.7m (WNWD.L) 

The Maritime AI company, announces the signing of a five-year contract with a European national coastguard (Customer). The contract has a total value of EUR3.2m (c. US$3.5m) which is expected to be paid in full up front, strengthening the Company's cash position, while the revenue will be recognised over the course of the contract, adding approximately $700k per year to Windward's Annual Contract Value. The Company is trading comfortably in line with market expectations and continues to see a strong pipeline. 

 

 

 

 

 

 

Status of this Note and Disclaimer

This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II       Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).

This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii)  persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

 
 
TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist